Skip to main content

Development of Targeted Nanoparticle, NanoGTP, a More Effective Treatment for Pancreatic and Lung Cancer

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Dec 10, 2012
Award amount: 
Organization name: 
Qualiber, Inc
Principal Investigator: 
Goyal, Anil K.
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Research Triangle

Qualiber develops human therapeutics using its proprietary nanoparticle drug delivery technology (nanoCLIPD) for more effective treatment of cancers.. The SRL funds will be used to develop processes for long term storage and scale up manufacturing of its lead molecule.

Fiscal year: